British Association for the Study of Headache response to the NICE Final Appraisal Determination (FAD) for erenumab for preventing migraine. Click here! for read complete BASH erenumab statement
Merton Sandler – obituary
Merton Sandler Professor Merton Sandler, one of the pioneers of modern Neuropharmacology, died on 24 August 2014 at the age of 88. He was born and educated in Manchester, and qualified in medicine from the University there in 1949. After serving in the Army and at the Royal Free Hospital as a junior pathologist, he…
Methysergide treatment can continue with new restrictions
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has conducted a review of the use of methysergide and has made new recommendations following reports of fibrosis seen with methysergide use. Fibrosis is a condition in which fibrous (scar) tissue accumulates in the body’s organs potentially damaging them.Read More
The 5th Keele Headache Teaching Course – 19th – 21st June 2014
This intensive teaching course aims to address the practical recognition and modern management of headache disorders highlighting recent advances in an interactive faculty environment. The course is largely focused on Neurology Trainees but is open to anyone interested in attending from professions allied to medicine. e.g. Consultant Neurologists or Physicians, Specialist Nurses, GPs, Physios, Pharmaceutical…
Headache Quality Standards Published
The National Institute for Health and Care Excellence (NICE) have published the Quality Standards for headache in young people and adults today. The quality standards refer to all primary headache disorders including migraine and apply to the NHS in England and Wales. BASH-Press-Statement – Headache Quality Standards Published